Peer-reviewed articles

Botta L, Gatta G, Trama A, et al. Incidence and survival of rare cancers in the US and Europe. Cancer Medicine. 2020;9(15):5632-5642. doi:10.1002/cam4.3137

O'Connor M, O'Donovan B, Waller J, et al. The role of healthcare professionals in HPV communication with head and neck cancer patients: A narrative synthesis of qualitative studies. Eur J Cancer Care (Engl). 2020;29(4):e13241. doi:10.1111/ecc.13241

Virgili G, Parravano M, Gatta G, et al. Incidence and Survival of Patients With Conjunctival Melanoma in Europe. JAMA Ophthalmol. 2020;138(6):601. doi:10.1001/jamaophthalmol.2020.0531

O'Connor M, Waller J, Gallagher P, et al. Barriers and facilitators to discussing HPV with head and neck cancer patients: A qualitative study using the theoretical domains framework. Patient Educ Couns. Published online May 30, 2020:S0738-3991(20)30318-9. doi:10.1016/j.pec.2020.05.032

Molina-Montes E, Van Hoogstraten L, Gomez-Rubio P, et al. Pancreatic Cancer Risk in Relation to Lifetime Smoking Patterns, Tobacco Type, and Dose-Response Relationships. Cancer Epidemiol Biomarkers Prev. 2020;29(5):1009-1018. doi:10.1158/1055-9965.EPI-19-1027

Cabasag CJ, Butler J, Arnold M, et al. Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based study. Gynecol Oncol. 2020;157(1):234-244. doi:10.1016/j.ygyno.2019.12.047

Schliemann D, Paramasivam D, Dahlui M, et al. Change in public awareness of colorectal cancer symptoms following the Be Cancer Alert Campaign in the multi-ethnic population of Malaysia. BMC Cancer. 2020;20(1):252. doi:10.1186/s12885-020-06742-3

O'Connor M, O'Donovan B, Waller J, et al. Communicating about HPV in the context of head and neck cancer: A systematic review of quantitative studies. Patient Educ Couns. 2020;103(3):462-472. doi:10.1016/j.pec.2019.09.017

EUROCARE-5 Working Group, Bielska-Lasota M, Rossi S, et al. Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study. Arch Gynecol Obstet. 2020;301(2):591-602. doi:10.1007/s00404-019-05412-5

O'Donovan B, Rodgers RM, Cox AR, Krska J. Use of information sources regarding medicine side effects among the general population: a cross-sectional survey. Prim Health Care Res Dev. 2019;20:e153. doi:10.1017/S1463423619000574

Keeling E, Murray SL, Williams Y, et al. Merkel cell carcinoma in kidney transplant recipients in Ireland 1964-2018. Br J Dermatol. 2019;181(6):1314-1315. doi:10.1111/bjd.18218

Menzies S, O'Leary E, Callaghan G, et al. Declining incidence of keratinocyte carcinoma in organ transplant recipients. Br J Dermatol. 2019;181(5):983-991. doi:10.1111/bjd.18094

Arnold M, Rutherford MJ, Bardot A, et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol. 2019;20(11):1493-1505. doi:10.1016/S1470-2045(19)30456-5

Quigley C, Deady S, Hughes E, McElnea E, Zgaga L, Chetty S. National incidence of eyelid cancer in Ireland (2005-2015). Eye (Lond). 2019;33(10):1534-1539. doi:10.1038/s41433-019-0437-8

O'Neill JP, Sexton DJ, O'Leary E, et al. Post-transplant malignancy in solid organ transplant recipients in Ireland, The Irish Transplant Cancer Group. Clin Transplant. 2019;33(10):e13669. doi:10.1111/ctr.13669

Gatta G, Botta L, Comber H, et al. The European study on centralisation of childhood cancer treatment. Eur J Cancer. 2019;115:120-127. doi:10.1016/j.ejca.2019.04.024

Araghi M, Soerjomataram I, Bardot A, et al. Changes in colorectal cancer incidence in seven high-income countries: a population-based study. Lancet Gastroenterol Hepatol. 2019;4(7):511-518. doi:10.1016/S2468-1253(19)30147-5

Donnelly C, Hart N, McCrorie AD, et al. Predictors of an early death in patients diagnosed with colon cancer: a retrospective case-control study in the UK. BMJ Open. 2019;9(6):e026057. doi:10.1136/bmjopen-2018-026057

Sexton DJ, O'Kelly P, O'Leary E, et al. Variation in Nonmelanoma Skin Cancer Incidence by Treatment Modality Among Patients Receiving Multiple Kidney Transplants. JAMA Dermatol. 2019;155(5):594-598. doi:10.1001/jamadermatol.2018.4660

Gomez-Rubio P, Piñero J, Molina-Montes E, et al. Pancreatic cancer and autoimmune diseases: An association sustained by computational and epidemiological case-control approaches. Int J Cancer. 2019;144(7):1540-1549. doi:10.1002/ijc.31866

Dunne S, Coffey L, Sharp L, et al. Investigating the impact of self-management behaviours on quality of life and fear of recurrence in head and neck cancer survivors: A population-based survey. Psychooncology. 2019;28(4):742-749. doi:10.1002/pon.5010

Doherty AM, Lorenz L, Jabbar F, O'Leary E, Casey P. Sleep Disturbance in Adjustment Disorder and Depressive Episode. Int J Environ Res Public Health. 2019;16(6). doi:10.3390/ijerph16061083

Dunne S, Coffey L, Sharp L, et al. Integrating self-management into daily life following primary treatment: head and neck cancer survivors' perspectives. J Cancer Surviv. 2019;13(1):43-55. doi:10.1007/s11764-018-0726-4

Ray-Coquard I, Trama A, Seckl MJ, et al. Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting. European Journal of Surgical Oncology. 2019;45(1):67-74. doi:10.1016/j.ejso.2017.09.025

Pasquali S, Bonvalot S, Tzanis D, et al. Treatment challenges in and outside a network setting: Soft tissue sarcomas. European Journal of Surgical Oncology. 2019;45(1):31-39. doi:10.1016/j.ejso.2017.09.015